Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Revance Therapeutics, Inc. | fy1910-kex322certifica.htm |
| EX-32.1 - EXHIBIT 32.1 - Revance Therapeutics, Inc. | fy1910-kex321certifica.htm |
| EX-31.2 - EXHIBIT 31.2 - Revance Therapeutics, Inc. | fy1910-kex312certifica.htm |
| EX-31.1 - EXHIBIT 31.1 - Revance Therapeutics, Inc. | fy1910-kex311certifica.htm |
| EX-10.43 - Revance Therapeutics, Inc. | fy1910-kexhibit1043teo.htm |
| EX-10.42 - EXHIBIT 10.42 - Revance Therapeutics, Inc. | fy1910-kex1042revancex.htm |
| EX-10.41 - EXHIBIT 10.41 - Revance Therapeutics, Inc. | fy1910-kex1041executiv.htm |
| EX-10.40 - EXHIBIT 10.40 - Revance Therapeutics, Inc. | fy1910-kex1040employme.htm |
| EX-10.28 - EXHIBIT 10.28 - Revance Therapeutics, Inc. | fy1910-kex1028mgtbonus.htm |
| EX-10.27 - EXHIBIT 10.27 - Revance Therapeutics, Inc. | fy1910-kex1027director.htm |
| EX-4.4 - EXHIBIT 4.4 - Revance Therapeutics, Inc. | fy1910-kex44descriptio.htm |
| 10-K - 10-K - Revance Therapeutics, Inc. | rvnc1231201910-k.htm |